Medeologix Acquires Mediballoon, MedeonBio and Second Source Medical

November 28, 2022

Medeologix, a Taiwan-based MedTech CDMO, acquired three Silicon Valley contract manufacturers — Mediballoon, MedeonBio and Second Source Medical — to create an integrated end-to-end medical device development and manufacturing group. The combined organization brings together tubing extrusion, balloon forming, catheter processing, assembly, packaging and regulatory support, and links U.S. development centers with Medeologix's mass-production facility in Taiwan to support scale-up and commercialization.

Buyers
Medeologix
Targets
Mediballoon, MedeonBio, Second Source Medical
Industry
Medical Devices
Location
California, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.